Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/10/757   
Active ingredient: Pomalidomide
Indication: Treatment of primary myelofibrosis
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2010 Centralised Orphan - Designation EMA/OD/161/09 (2010)5341 of 27/07/2010
30/05/2011 Other procedure EMEA/OD/161/09